One in five U.S. adults lives with a mental illness, yet only a fraction of philanthropic dollars goes toward mental health, addiction, and well-being. Alyson Niemann, CEO of Mindful Philanthropy, joined Conversations on Health Care hosts Mark Masselli and Margaret Flinter to share how her organization is closing this gap and inspiring bold new investments.

“We issued a challenge … to increase the funding to mental health, addiction, and well-being to $35 billion annually by 2035,” Niemann explained during the interview at the Aspen Ideas: Health conference. “If invested in the right places, it can produce incredible savings, economic productivity, and well-being across our entire ecosystem.”

Mindful Philanthropy is convening more than 1,100 funders across all 50 states; launching state-based collaboratives; and connecting funders, uplifting community-led solutions, and providing strategic guidance to break down silos and scale impact.

“We’re hoping to have all of those [funder collaboratives] learn from one another,” Niemann said, underscoring the power of collaboration to advance lasting change.

Whether it’s strengthening the mental health workforce, supporting youth from birth to young adulthood, or investing in community-rooted solutions, this conversation offers practical and inspiring insights for anyone passionate about building a healthier future.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Experts who believe in the “food is medicine” concept say recent decisions made in Washington could have a devastating effect. Dr. Hilary Seligman, a nationally recognized expert on food insecurity and health outcomes at the University of California San Francisco, spoke to “Conversations on Health Care.” The interview highlighted that cutbacks to the Supplemental Nutrition Assistance Program (SNAP) are projected to reduce federal spending by $186 billion over the next decade. She believes this could result in more people getting sicker and then ending up in emergency departments with severe conditions.

Yet Dr. Seligman also sees some rays of optimism. “This administration has done a really deep dive into chronic disease. There is a desire to help make the population of the U.S. healthier again. And there is an interest in supporting better dietary intake. The challenge is to amplify those efforts in a way that is based in science, that is based in evidence and that will support everyone in the U.S. equally. That really is the opportunity that we have,” she told hosts Mark Masselli and Margaret Flinter.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Americans are living longer for many reasons and experts credit Medicare and Medicaid for some of this success. This week, these federal programs are celebrating their own birthdays. Sixty years ago, President Lyndon B. Johnson signed Medicare and Medicaid into law.

However, recent moves are expected to result in decreased enrollment and payments to health care providers. “Conversations on Health Care” hosts Mark Masselli and Margaret Flinter speak with Mark Updegrove about this situation. Updegrove is the president and CEO of the LBJ Foundation, presidential historian for ABC News and a recent guest on “The View.”

Join us for this important conversation, which examines the history and continuing impact of how we pay for health care for some of our most vulnerable neighbors.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

“I would have never, ever in my whole life have said, ‘we’re going to cure addiction.’ I think we now have knowledge and tools that could potentially, definitely lead us to a cure for addiction.”

— Dr. Nora Volkow, Director, National Institute on Drug Abuse

Dr. Volkow shared her attention-getting belief with “Conversations on Health” at Aspen Ideas: Health. Healthcare providers and society at large have spent decades dealing with substance use disorders and the loss of life has been staggering. Dr. Volkow leads NIDA, the world’s largest funder of biomedical research on addiction, and she explains why she’s so confident with her assessment:

The wider availability of naloxone and knowledge about how to quickly use it when needed;

Neuroplasticity as a pathway to recovery; and

Perhaps surprisingly, smartphones and video games are so distracting to some young people that they no longer need to seek other forms of escape.

Join hosts Mark Masselli and Margaret Flinter as Dr. Volkow also explains the challenges and opportunities for NIDA within the National Institutes of Health.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

If you ran a healthcare foundation worth nearly $1 billion, where would you invest those dollars? That a question Dr. Joseph Betancourt, his colleagues and board members get to tackle every day.

Dr. Betancourt, president of the influential The Commonwealth Fund, is committed to “Affordable, quality health care. For everyone.” Hosts Mark Masselli and Margaret Flinter interviewed him at Aspen Ideas: Health at the Aspen Institute.

Here are some of the Fund’s top concerns right now:

1. Private equity: The Commonwealth Fund is examining how private equity engages in healthcare delivery and what impact it’s having on cost, quality and safety. Dr. Betancourt explains that its new strategic plan will focus on commercial drivers and the tension between patients and profits.
2. Primary care: There’s a growing crisis, exacerbated by fewer primary care medical students and a culture that doesn’t appreciate their contributions.
3. Outcomes: The Fund’s Scorecard on State Health System Performance found the number of children who have received all doses of the seven recommended early childhood vaccines is below 75% in most states.

Dr. Betancourt, the first Latino to lead the Fund, is also proud of health equity as he defines it:

“My lived experience informs a lot of my ideas around how our foundation can go forward…it’s about respect and making sure we’re not leaving anyone behind, that we and I do the best for everyone. Those are the values I bring personally. Those are the values I bring as a clinician. And those are the values that are very well aligned with the Commonwealth Fund,” he says.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

President Trump signed the “One Big Beautiful Bill Act” into law on July 4 and now leaders such as Stephanie Carlton are in charge of implementing it. She’s the deputy administrator and chief of staff at the Centers for Medicare & Medicaid Services.

Carlton and the administration see the law’s benefits because Medicaid reimbursement rates “were allowed to go up to commercial rates and states are at varying levels towards that cap. But as we sat back and looked at it and said well, ‘these are providers who are committing to society to vulnerable Americans that they’re going to help with their healthcare needs’…. but paying up to commercial rates kind of changes the focus of the program, where it becomes more about facilities profiting more than making sure patients are taken good care of.”

Carlton also answered questions from hosts Mark Masselli and Margaret Flinter shortly before Congress passed the bill. In addition, she discussed how they believe modern technology can help with new Medicaid work requirements, concerns about the National Health Service Corps and the administration’s plans to lower prescription drug costs.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

There’s a lot of attention right now around “super agers.” Yet the facts are that current life expectancy at birth is 74.8 years for males and for females it’s 80.2 years in the U.S.

Does it catch your eye when you hear about predictions we’ll be able to live to 100 and beyond?

Some researchers are throwing cold water on those notions.

“We’ll be lucky if 5% of the age cohort makes it to 100,” says S. Jay Olshansky, Ph.D., Professor, University of Illinois at Chicago. He and his colleagues made headlines when they presented data that humans are approaching a biologically-based limit to life.

Hosts Mark Masselli and Margaret Flinter ask Olshansky about the implications of this research — for each of us personally and for policymakers — after decades of hearing predictions that life expectancy would continue to go up. Olshanky explains why we should celebrate longer life that has resulted from healthier diets and medical advances but now focus on improving quality of life in later years.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Millions are still living with the effects of Long COVID and new research shows that for older adults, the consequences may be profound and lasting.

In part one of a special two-part series on “Conversations on Health Care,” Dr. Gabriel de Erausquin, a neurologist and leading Long COVID researcher at the University of Texas Health San Antonio, shares groundbreaking findings from his global study of over 3,500 patients. His work reveals a troubling connection: many Long COVID patients over 60 show cognitive decline that mirrors early signs of dementia.

“The parts of the brain that are affected by COVID overlap significantly with those that are affected early in the course of Alzheimer’s….the changes overlap, but they are not identical.”

His team is now studying brain imaging and biomarkers to understand the link between COVID-related cognitive decline and traditional neurodegenerative diseases like Alzheimer’s disease.

Dr. de Erausquin also explains how persistent loss of smell — a hallmark COVID symptom — may be the strongest predictor of ongoing cognitive issues, and how genetic sequencing is helping uncover inherited risk.

He highlights a dual reality: while many Long COVID patients show biological changes, others had prior diagnoses of depression, anxiety, or chronic fatigue — a nuance often missing from public conversations.

Click to hear the full conversation with hosts Mark Masselli and Margaret Flinter.

“Originally aired on May 15, 2025”

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.